TGA Approval

CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials (203313)

ARTG ID

203313

ARTG Name

CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials

Sponsor

Chiesi Australia Pty Ltd

ARTG Date

June 27, 2013

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

CHIESI AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01627-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-01626-1

Ingredient Name

clevidipine

Empowering clinical research with data-driven insights and AI-powered tools.

CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials (203313) - TGA 批准文号 | MedPath